http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
임청산,이광호,권기록,Lim, Chung-San,Lee, Kwang-Ho,Kwon, Ki-Rok 대한약침학회 2010 Journal of pharmacopuncture Vol.13 No.3
Objectives: This study was performed to analyse the effects of Sweet Bee Venom(Sweet BV) on cardiovascular system in the conscious telemetered Beagle Dogs. Methods: All experiments were conducted at Biotoxtech Company, a non-clinical studies authorized institution, under the regulations of Good Laboratory Practice (GLP). Male Beagle dogs of 13-19 months old were chosen for the pilot study and surgical implantation was performed for conscious telemetered Beagle dogs. And after confirming condition of Beagle dogs was stable, Sweet BV was administered 4 times(first: 0.0 mg/kg, 2nd: 0.01 mg/kg, 3rd: 0.1 mg/kg, and forth: 0.5 mg/kg, one time/week) in thigh muscle of Beagle dogs. And blood pressure, heart rate, electrocardiography and clinical responses were measured. Equal amount of normal saline to the Sweet BV experiment groups was administered to the control group. Results: 1. In the analysis of body weight and taking amount, Beagle dogs did not show significant changes. 2. In the clinical observation, responses of pain and edema were showed depend on dosage of Sweet BV. 3. In the analysis of blood pressure, treatment with Sweet BV did not show significant changes in the dosage of 0.01 mg/kg, but in the dosage of 0.1 mg/kg and 0.5 mg/kg, treatment with Sweet BV increased blood pressure significantly. 4. In the analysis of heart rate, treatment of Sweet BV did not show significant changes in all dosage and period. 5. In the analysis of electrocardiography, treatment of Sweet BV was not showed significant changes in all dosage and period. Conclusion: Above findings suggest that Sweet BV is relatively safe treatment in the cardiovascular system. But in the using of over dosage, Sweet BV may the cause of increasing blood pressure. Further studies on the subject should be conducted to yield more concrete evidences.
Plexiform Neurofibroma Treated with Pharmacopuncture
임청산,권기록,이광호 대한약침학회 2014 Journal of pharmacopuncture Vol.17 No.3
Objectives: The purpose of this study is to report a case of a plexiform neurofibroma (PNF) in the pelvic region treated with sweet bee venom (SBV) and mountain ginseng pharmacopuncture (MGP). Methods: A 16-year-old girl was diagnosed as having PNFs, neurofibromatosis type 1, 10 years ago and she had surgery three times to remove the benign tumors, but the growth of the PNFs continued. She has been treated in our clinic with SBV and MGP two times per month from March 2010 to April 2014. SBV was injected intra-subcutaneously at the borders of the PNFs in the pelvic region, and MGP was administrated intravenously each treatment time. Results: The growths of the PNFs occurred rapidly and continued steadily before treatment. Since March 2010, she has been treated in our clinic, and the growths of the PNFs have almost stopped; further-more, the discomfort of hip joint pain has been reduced, and her general condition has improved. Conclusion: We cautiously conclude that SBV and MGP treatment has some effects that suppress the growth and the spread of the PNFs in this patient.
Research on Korean Pharmacopuncture in South Korea since 2007
임청산,박상권,선승호,이광호 대한약침학회 2014 Journal of pharmacopuncture Vol.17 No.4
Objectives: The purpose of this study was to investigatethe current trends in research on pharmacopuncture inKorea since 2007. Methods: A literature review was performed by usingthe search engines ‘Science and Technology SocietyVillage’, ‘Korean Studies Information Service System’,‘National Discovery for Science Leaders’, and ‘OrientalMedicine Advanced Searching Integrated System’ inKorea from January 2007 to December 2013. Searchedkey words were ‘pharmacopuncture’, ‘herbal acupuncture’,‘aqua-acupuncture’, and ‘bee venom’. Finally, weselected 457 papers, including Korean experimentalstudies and clinical studies. Selected papers were classifiedaccording to year of publication, type of pharmacopuncture,disease & topic, research type and the publishingjournal. Results: One hundred fifty pharmacopunctures werestudied in 457 papers. Single compound pharmacopuncturewas the most studied pharmacopuncture inexperimental studies while animal-based pharmacopuncturewas the most studied pharmacopuncture inclinical studies. Bee venom placed first among the variouspharmacopunctures, followed by placenta, sweetbee venom, mountain-ginseng, and anti-inflammatorypharmacopunctures. Experimental research on pharmacopuncturehas fallen since 2007 when 55 paperswere published. However, clinical research has been increasing steadily. In clinical studies, case reports werenumerous than randomized clinical trials (RCTs). Musculoskeletaldiseases were the most frequently-treateddiseases in studies on pharmacopuncture; among themusculoskeletal diseases, rheumatoid arthritis was themost frequently-treated disease in experimental studiesand low back pain was the most frequently-treatedcondition in clinical studies. Since 2007, 45 differentjournals have published studies on pharmacopuncture,with the Journal of the Korean Acupuncture andMoxibustion Medicine Society having the largest numberof papers on pharmacopuncture and the Journal ofPharmacopuncture the second largest number. Conclusion: The trends in research on pharmacopuncturepublished in studies from 2007 to 2013 weresimilar to those in studies published before 2006. Many studies on pharmacopuncture focused on beevenom and musculoskeletal diseases. Additional studieson diverse types of and indications for pharmacopunctureare needed.